KAZIA THERAPEUTICS LTD — Investor Relations & Filings
Filings indexed
1,045
across all filing types
Latest filing
2026-06-02
Regulatory Filings
Country
US
United States of America
Listing
US
KZIA
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company engaged in the development of innovative drugs for cancer. The company's lead program is paxalisib, a small molecule inhibitor of the PI3K/AKT/mTOR pathway designed to cross the blood-brain barrier, which is being investigated for various forms of brain cancer. Its development pipeline also includes EVT801, a selective VEGFR3 inhibitor being studied for its potential to block the growth of blood and lymphatic vessels that support tumor growth. The company focuses on addressing cancers with high unmet medical needs through its portfolio of targeted therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| PROSPECTUS SUPPLEMENT | 2026-06-02 | English | |
| PROSPECTUS SUPPLEMENT | 2026-06-02 | English | |
| PROSPECTUS SUPPLEMENT | 2026-06-02 | English | |
| PROSPECTUS SUPPLEMENT | 2026-06-02 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-06-02 | English | |
| PROSPECTUS SUPPLEMENT | 2026-05-26 | English |
Browse filings by year
23 years- 2026 40 filings
- 2025 103 filings
- 2024 86 filings
- 2023 37 filings
- 2022 25 filings
- 2021 28 filings
- 2020 34 filings
- 2019 33 filings
- 2018 37 filings
- 2017 46 filings
- 2016 38 filings
- 2015 64 filings
- 2014 24 filings
- 2013 91 filings
- 2012 50 filings
- 2011 40 filings
- 2010 35 filings
- 2009 31 filings
- 2008 45 filings
- 2007 63 filings
- 2006 58 filings
- 2005 30 filings
- 2004 7 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47934355 | PROSPECTUS SUPPLEMENT | 2026-06-02 | English | ||
| 47934357 | PROSPECTUS SUPPLEMENT | 2026-06-02 | English | ||
| 47934364 | PROSPECTUS SUPPLEMENT | 2026-06-02 | English | ||
| 47934362 | PROSPECTUS SUPPLEMENT | 2026-06-02 | English | ||
| 47934277 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-06-02 | English | ||
| 47061348 | PROSPECTUS SUPPLEMENT | 2026-05-26 | English | ||
| 47061194 | PROSPECTUS SUPPLEMENT | 2026-05-26 | English | ||
| 47061349 | PROSPECTUS SUPPLEMENT | 2026-05-26 | English | ||
| 47061193 | PROSPECTUS SUPPLEMENT | 2026-05-26 | English | ||
| 47061004 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-26 | English | ||
| 37441472 | 6-K - KAZIA THERAPEUTICS LTD (0001075880) (Filer) | 2026-04-27 | English | ||
| 34578390 | 424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer) | 2026-04-15 | English | ||
| 34578387 | 424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer) | 2026-04-15 | English | ||
| 34578386 | 424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer) | 2026-04-15 | English | ||
| 34578384 | 424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer) | 2026-04-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
KAZIA THERAPEUTICS LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35206/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35206 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35206 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35206 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35206}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for KAZIA THERAPEUTICS LTD (id: 35206)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.